FDA Inspection 568132 — Texas Oncology, P.A. - South Texas Cancer Center
The FDA completed an inspection of Texas Oncology, P.A. - South Texas Cancer Center on February 10, 2009 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 10, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mcallen, TX (United States)